About us

COBRAIN is the first-time-ever succeeded Horizon 2020 project in Yerevan State Medical University. Its direct objective is to enhance the research and innovation capacity of the University through strengthening the field of brain research with a special emphasis on neuroprotective cell-based and drug therapies of brain disorders. By getting closer to the expertise of Eberhard Karls University of Tuebingen, Ruhr-University Bochum and Lund University the project will address sub-objectives for establishing neuroscience research structure, investing in early stage researchers, broadening research career opportunities, building innovation capacity, increasing the visibility of the University.

Advisory Board

Artem Patapoutian

Nobel Prize in Physiology and Medicine

Read More
Aaron Ciechanover

M.D., DSc., distinguished research professor, Laureate of the 2004 Nobel Prize in Chemistry

Read More
Zaven Khachaturian

PhD, President, “Campaign to Prevent Alzheimer 2020”, Editor-in-Chief, Alzheimer’s & Dementia: J. Alz. Assoc.

Read More
Armen Muradyan

YSMU Rector, Professor

Read More
Allan V. Kalueff

PhD, Professor of Neuroscience Director, ZENEREI Research Center, Neuroscience and Pharmacology Lab

Read More
Nicole Deglon

Head of the Laboratory of Cellular and Molecular Neurotherapies, Lausanne University Hospital

Read More
Jacek Jaworski

PhD, Full Professor, Deputy Director for Science & Head of Lab, International Institute Of Molecular and Cell Biology

Read More

Scientific Directions

NEURODEGENERATION: ALZHEIMER’S DISEASE

The aim is to implement the complex study of neuronal damage and their survival pathways in Alzheimer’s disease.

AUTISM

The aim is to study the pathogenesis of nervous system developmental disorders exemplified on autism and assessment of their animal models.

Events

Nov 29, 2024 Nov 28, 2024 May 16, 2024